Purchase Order 75N93018P00955
Award Date
9/13/18
Potential Completion Date
4/6/23
Potential Value
$98K
Federal Agency
National Institute of Allergy and Infectious Diseases
Awardee
Geneimmune Biotechnology Corp
Ultimate Awardee
Not listed
NAICS Category
541380 - Testing Laboratories and Services
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Derwood, MD 20855, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price purchase order awarded by the National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) to Geneimmune Biotechnology Corp, a for-profit Asian-Pacific American-owned biotechnology company based in Rockville, MD. The contract is for $151,620.00 and covers site-directed mutagenesis, gene synthesis, and plasmid preparation services in support of COVID-19 research. The contract was awarded on a sole-source basis pursuant to FAR...
This is a firm fixed-price purchase order contract awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp, a small, Asian-Pacific American-owned biotechnology company based in Rockville, Maryland. The contract, valued at $98,958.95, is for the provision of various research and development services related to genetics, immunology, virology, and infectious diseases, including...
This is a firm fixed-price purchase order contract awarded to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $50,955 contract is for subcloning, mutagenesis, and DNA preparation test services, and was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), which is part of the Department of Health and Human Services' National Institutes of Health. The contract has an ultimate completion date of January 19, 2015 and was awarded on...
The Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases (NIAID) awarded a $149,960.00 firm fixed price purchase order contract to Geneuniversal Inc., a for-profit biotechnology company, for gene synthesis, site-directed mutagenesis, PCR cloning, and plasmid preparation services. This award supports the NIH Vaccine Research Center's efforts to develop vaccines and antibodies against HIV and other viruses, by...
This is a firm fixed-price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The contract has a potential value of $12,265.00 and is focused on DNA preparation services. The contract was set aside for small businesses and does not appear to be associated with a larger contract vehicle. Geneimmune...
This is a $200,219.00 firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (NIH) to Geneuniversal Inc., a for-profit biotechnology services provider based in Newark, Delaware. The contract is for DNA services including antibody gene synthesis, subcloning, and plasmid preparation to support the Vaccine Research Center's (VRC) efforts to develop vaccines against HIV/AIDS. This is a follow-on requirement to...
This federal contract award is for site-directed mutagenesis services (Catalog #GI-M100) provided by Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, MD. The $9,994.40 firm fixed price contract was awarded on September 22, 2010 by the National Institutes of Health's National Institute of Allergy and Infectious Diseases (NIAID). The contract has an ultimate completion date of September 30, 2010 and does not have a set-aside designation. Geneimmune Biotechnology Corp....
The Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases awarded a $34,697.53 firm fixed price purchase order to Genscript USA Inc. to provide DNA services in support of vaccine development efforts. Under the contract, Genscript will deliver gene synthesis, VectorArk cloning, and express plasmid preparation services. These services will enable the creation of peptide and protein immunogens as well as DNA constructs containing...
This firm fixed price purchase order was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the U.S. Department of Health and Human Services, to Geneimmune Biotechnology Corp., a biotechnology company based in Rockville, Maryland. The $31,435.00 contract is for the production of 20 liters of monoclonal antibodies at $1,500 per liter. This award supports NIAID's infectious disease research efforts, leveraging Geneimmune's expertise in areas such as gene...
This is a firm fixed price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to GeneUniversal Inc., a small business located in Newark, Delaware. The $99,794.60 contract is for gene synthesis services, including subcloning, site-directed mutagenesis, PCR cloning, and plasmid preparation. The contract is not set aside and was awarded on a sole source basis, as NIAID determined GeneUniversal...